Search

BR-102024018036-A2 - Medicinal formulation-enhanced bandage for use in the preparation of Unna boots, production process for medicinal formulation-enhanced bandage for use in the preparation of Unna boots, medicinal formulation for use as an additive in a bandage for use in the preparation of Unna boots, and medicinal formulation application equipment for the production of medicinal formulation-enhanced bandage for use in the preparation of Unna boots.

BR102024018036A2BR 102024018036 A2BR102024018036 A2BR 102024018036A2BR-102024018036-A2

Abstract

This patent application proposes a bandage (1) enriched with a medicinal formulation (12) applied using equipment (2), wherein said enriched bandage (1) is intended for use in the preparation of “Unna Boot” (UB) useful as a means of treating ailments such as Sickle Cell Anemia, Lymphedema and Vascular Injury. The object now proposed thus integrates, in general, products for hospital and/or outpatient use aimed at performing dressings and similar procedures. The production process of the enriched bandage (1) foresees that said bandage is impregnated using equipment (2), thus generating an impregnated enriched bandage (1), which is subsequently cut into sections of the bandage to obtain individual bandages.

Inventors

  • MARCOS ANTONIO GUEDES DE ALBUQUERQUE

Assignees

  • Marcos Antônio Guedes De Albuquerque

Dates

Publication Date
20260317
Application Date
20240902

Claims (13)

  1. 1. "ADDED BANDAGE WITH MEDICINAL FORMULATION FOR USE IN THE PREPARATION OF UNNA BOOTS", of the type that is constituted of Polyamide and Cotton and that is intended for the preparation of "Unna Boots" (UB), characterized by the added bandage (1) incorporating a load of medicinal formulation containing: Carapa Guaianensis (Andiroba Oil) in a proportion of 1%, Melia Azadirachta Seed Oil (Neem Oil) in a proportion of 1%, Carica Papaya Extract Fermented (Fermented Papaya Extract) in a proportion of 10%, Melaleuca Alternifolia Oil (Tea Tree Oil) in a proportion of 1%, Aloe Barbadensis Leaf Extract (Aloe Vera Leaf Extract) in a proportion of 1%, Paraffinum Liquidum (Mineral Oil) in a proportion of 2%, Cetearyl Alcohol (Cetotearyl Alcohol) in a proportion of 2%, Ceteareth 20 (Ethoxylated Cetostearyl Alcohol) in a proportion of 2%; Butyl Hydroxytoluene (BHT) at a ratio of 0.05%, Disodium EDTA at a ratio of 0.10%, Aminomethyl Propanol at a ratio of 0.30%, Rosmarinus Officinalis Extract (Rosemary Extract) at a ratio of 1%, Caprylyl Glycol at a ratio of 0.35%, Phenoxyethanol at a ratio of 0.65%, Acacia Senegal (Gum Arabic) at a ratio of 1%, Glycerin at a ratio of 3%, Arnica Montana Flower Extract at a ratio of 2%, Lanolin at a ratio of 5%, Zinc Oxide at a ratio of 0.50%, and Water QSP.
  2. 2. "ADDED BANDAGE WITH MEDICINAL FORMULATION FOR USE IN THE PREPARATION OF UNNA'S BOOT", according to claim 1, characterized in that the added bandage (1) has a variant in its medicinal formulation load, in which said medicinal formulation load contains: Carapa Guaianensis (Andiroba Oil) in a proportion of 1%, Melia Azadirachta Seed Oil (Neem Oil) in a proportion of 1%, Carica Papaya Extract Fermented (Fermented Papaya Extract) in a proportion of 10%, Melaleuca Alternifolia Oil (Tea Tree Oil) in a proportion of 1%, Aloe Barbadensis Leaf Extract (Aloe Vera Leaf Extract) in a proportion of 1%, Paraffinum Liquidum (Mineral Oil) in a proportion of 2%, Cetearyl Alcohol (Cetotearyl Alcohol) in a proportion of 2%, Ceteareth 20 (Ethoxylated Cetostearyl Alcohol) in a proportion of 2%; Butyl Hydroxytoluene (BHT) in a proportion of 0.05%, Disodium EDTA in a proportion of 0.10%, Aminomethyl Propanol in a proportion of 0.30%, Rosmarinus Officinalis Extract (Rosemary Extract) in a proportion of 1%, Caprylyl Glycol in a proportion of 0.35%, Phenoxyethanol in a proportion of 0.65%, Acacia Senegal (Gum Arabic) in a proportion of 1%, Glycerin in a proportion of 3%, Arnica Montana Flower Extract in a proportion of 2%, Lanolin in a proportion of 5%, and Water QSP.
  3. 3.-"ADDED BANDAGE WITH MEDICINAL FORMULATION FOR USE IN THE PREPARATION OF UNNA BOOTS", according to claim 1, characterized in that the bandage (1) has an additive proportion of Polyamide and Cotton of 70% Polyamide and 30% Cotton.
  4. 4.-"BANDAGE ADDED WITH MEDICINAL FORMULATION FOR USE IN THE PREPARATION OF UNNA BOOTS", according to claims 1 or 2, characterized in that the bandage (1) has an additive proportion of Polyamide and Cotton of 50% Polyamide and 50% Cotton.
  5. 5.-"BANDAGE ADDED WITH MEDICINAL FORMULATION FOR USE IN THE PREPARATION OF UNNA BOOTS", according to claim 1 or 2, characterized in that the bandage (1) has an additive proportion of Polyamide and Cotton of 80% Polyamide and 20% Cotton.
  6. 6.-“PROCESS FOR PRODUCING A BANDAGE ADDED WITH A MEDICINAL FORMULATION FOR USE IN THE PREPARATION OF UNNA BOOTS”, the process uses the medicinal formulation defined in claim 1 and starts with, as input, a bandage (1) made of Polyamide and Cotton, being characterized by having a first stage, in which the coil (3) of the bandage not yet impregnated is fed into the equipment (2); a second stage in which the volume of medicinal formulation (12) is loaded into the impregnation tank (4) of the equipment (2), a third stage in which the impregnation of the additive bandage (1) with the volume of medicinal formulation (12) is carried out, a fourth stage in which the excess of the medicinal formulation (12) impregnated in the additive bandage (1) is removed, a fifth stage in which the additive bandage (1) is wound onto the final bandage reel (22), a sixth stage which consists of cutting sections of the additive bandage (1) and winding them onto the final bandage reel (22) to obtain individual additive bandages (1) and a seventh stage which consists of packaging the individual additive bandages (1); the process results in an additive bandage (1) to be used in the preparation of an “Unna Boot” (UB).
  7. 7.-“PROCESS FOR PRODUCING A BANDAGE ADDED WITH A MEDICINAL FORMULATION FOR USE IN THE PREPARATION OF UNNA BOOTS”, the process uses the medicinal formulation defined in claim 2 and starts, as input, with a bandage (1) made of Polyamide and Cotton that includes Zinc Oxide and is characterized by having a first stage, in which the coil (3) of the bandage not yet impregnated is fed into the equipment (2); a second stage in which the volume of medicinal formulation (12) is loaded into the impregnation tank (4) of the equipment (2), a third stage in which the impregnation of the additive bandage (1) with the volume of medicinal formulation (12) is carried out, a fourth stage in which the excess of the medicinal formulation (12) impregnated in the additive bandage (1) is removed, a fifth stage in which the additive bandage (1) is wound onto the final bandage reel (22), a sixth stage which consists of cutting sections of the additive bandage (1) and winding them onto the final bandage reel (22) to obtain individual additive bandages (1) and a seventh stage which consists of packaging the individual additive bandages (1); the process results in an additive bandage (1) to be used in the preparation of an “Unna Boot” (UB).
  8. 8.-“PROCESS FOR PRODUCING A BANDAGE ADDED WITH A MEDICINAL FORMULATION FOR USE IN THE PREPARATION OF UNNA BOOTS”, according to claim 6, characterized by employing, as an input, bandage (1) originally produced and containing bioactive minerals that exhibit long-wave infrared radiation emission.
  9. 9.-“PROCESS FOR PRODUCING A BANDAGE WITH A MEDICINAL FORMULATION FOR USE IN THE PREPARATION OF UNNA BOOTS”, according to claim 7, characterized by employing, as an input, bandage (1) originally produced and containing bioactive minerals that exhibit long-wave infrared radiation emission.
  10. 10. “MEDICINAL FORMULATION FOR USE AS AN ADDITIVE IN A BANDAGE FOR USE IN THE PREPARATION OF UNNA BOOTS”, the medicinal formulation (12) employed in the additivated bandage (1) defined in claim 1 being used in the preparation of “Unna Boots” (UB), characterized by having said medicinal formulation (12): Carapa Guaianensis (Andiroba Oil) in a proportion of 1% and acting as an Emollient, Melia Azadirachta Seed Oil (Neem Oil) in a proportion of 1% and acting as an emollient, Carica Papaya Extract Fermented (Fermented Papaya Extract) in a proportion of 10% and acting as a Tonic, Melaleuca Alternifolia Oil (Tea Tree Oil) in a proportion of 1% and acting as an Antimicrobial Agent, Aloe Barbadensis Leaf Extract (Aloe Vera Leaf Extract) in a proportion of 1% and that Acts as a moisturizer, Paraffinum Liquidum (Mineral Oil) at a proportion of 2%, which acts as an emollient, Cetearyl Alcohol at a proportion of 2%, which acts as an emulsifier, Ceteareth 20 (Ethoxylated Cetostearyl Alcohol) at a proportion of 2%, which acts as an emulsifier, Butyl Hydroxytoluene (BHT) at a proportion of 0.05%, which acts as an antioxidant, Disodium EDTA at a proportion of 0.10%, which acts as a sequestrant, Aminomethyl Propanol at a proportion of 0.30%, which acts as a neutralizer, Rosmarinus Officinalis Extract (Rosemary Extract) at a proportion of 1%, which acts as an antiseptic agent, Caprylyl Glycol at a proportion of 0.35% acting as a preservative, Phenoxyethanol at a proportion of 0.65% acting as a preservative, Acacia Senegal (Gum Arabic) at a proportion of 1% acting as a viscosity controller, Glycerin at a proportion of 3% acting as a humectant, Arnica Montana Flower Extract at a proportion of 2% acting as an antiseptic, Lanolin at a proportion of 5% acting as an emollient, Zinc Oxide at a proportion of 0.50% acting as a dermal protector, and Water QSP acting as a vehicle.
  11. 11. “MEDICINAL FORMULATION FOR USE AS AN ADDITIVE IN A BANDAGE FOR USE IN THE PREPARATION OF UNNA BOOTS”, the medicinal formulation (12) employed in the bandage (1) with additives defined in claim 2 being used in the preparation of “Unna Boots” (UB), characterized by having said medicinal formulation (12) an alternative version that presents: Carapa Guaianensis (Andiroba Oil) in a proportion of 1% and which acts as an Emollient, Melia Azadirachta Seed Oil (Neem Oil) in a proportion of 1% and which acts as an emollient, Carica Papaya Extract Fermented (Fermented Papaya Extract) in a proportion of 10% and which acts as a Tonic, Melaleuca Alternifolia Oil (Tea Tree Oil) in a proportion of 1% and which acts as an Antimicrobial Agent, Aloe Barbadensis Leaf Extract (Aloe Vera Leaf Extract) in a proportion 1%, acting as a moisturizer; Paraffinum Liquidum (Mineral Oil) at a proportion of 2%, acting as an emollient; Cetearyl Alcohol at a proportion of 2%, acting as an emulsifier; Ceteareth 20 (Ethoxylated Cetostearyl Alcohol) at a proportion of 2%, acting as an emulsifier; Butyl Hydroxytoluene (BHT) at a proportion of 0.05%, acting as an antioxidant; Disodium EDTA at a proportion of 0.10%, acting as a sequestrant; Aminomethyl Propanol at a proportion of 0.30%, acting as a neutralizer; Rosmarinus Officinalis Extract (Rosemary Extract) at a proportion of 1%, acting as an antiseptic agent; Caprylyl Glycol (Caprylyl Glycol) at a proportion of 0.35%, acting as a preservative; Phenoxyethanol at a proportion of 0.65%, acting as a preservative; Acacia Senegal (Gum Arabic) at a proportion of 1%, acting as a viscosity controller; Glycerin at a proportion of 3%, acting as a humectant; Arnica Montana Flower Extract at a proportion of 2%, acting as an antiseptic; Lanolin at a proportion of 5%, acting as an emollient; and Water QSP, acting as a vehicle.
  12. 12.-“MEDICINAL FORMULATION APPLICATION EQUIPMENT FOR THE PRODUCTION OF ADDED BANDAGES FOR USE IN THE PREPARATION OF UNNA BOOTS”, the equipment (2) being used to obtain the added bandage (1), characterized by being constituted of an impregnation tank (4) mounted on a structural bench (5) equipped with legs (6), the equipment (2) has a shaft (7) which in turn is incorporated into a lateral support arm (8), which, in turn, is incorporated into the structural bench (5); the equipment (2) is also equipped with a first shaft (9) which is mounted horizontally against the structural chassis (10) of the body of the equipment (2), this first shaft (9) being equipped with a limiting ring (11); The impregnation tank (4) has a lower wall (13) near which the bandage centering weight (14) is positioned, which is formed by two parallel cylindrical bars (15) joined by two connecting bars (16), between which a handle (17) is mounted, each of the parallel cylindrical bars (15) has a pair of spacer projections (18) on its lower portion, spacer projections (18); the equipment (2) also incorporates a pair of excess removal rollers (19), one of which (19A) has the possibility of horizontal movement of approach or departure against the other excess removal roller (19) by means of the excess removal roller regulating handle (20); a scraper fork (21) is mounted laterally on the structural chassis (10); a rotating shaft (23) is provided which is moved manually by means of an external crank (24).
  13. 13.-“MEDICINAL FORMULATION APPLICATION EQUIPMENT FOR THE PRODUCTION OF ADDED BANDAGES FOR USE IN THE PREPARATION OF UNNA BOOTS”, according to claim 11, characterized in that the shaft (7) receives the bandage coil (3) yet to be impregnated and the rotating shaft (23) receives the final bandage coil (22), in which the added and already impregnated bandage (1) is located.

Description

FIELD OF APPLICATION [001] This report describes a Patent Application for Invention proposing a bandage enhanced with a medicinal formulation for use in the preparation of "Unna Boots," which is configured as a type of dressing that can be used on skin lesions such as Sickle Cell Anemia, Lymphedema, and Vascular Injury. The object now proposed thus generally integrates the field of products for hospital and/or outpatient use aimed at performing dressings and similar procedures. PREAMBLE [002] This Invention Patent application proposes a bandage specifically designed for the preparation of an "Unna Boot," which is innovative in that it is produced so that a load of medicinal formulation can be incorporated into the bandage structure itself, acting actively in the treatment of skin lesions such as Sickle Cell Anemia, Lymphedema, and Vascular Injury. This Invention Patent application also deals with the production process of a bandage with an additive medicinal formulation for use in the preparation of an "Unna Boot," the medicinal formulation for use as an additive in the bandage, and the equipment through which the medicinal formulation is applied to the bandage structure in order to obtain the final product, which is the bandage with additives for use in the preparation of an "Unna Boot." STATE OF THE ART [003] In 1882, the German dermatologist Paul Gerson Unna developed a zinc oxide paste to treat venous stasis dermatitis and later combined this paste with a bandage, which became the principle of Active Compression Therapy for venous ulcers known as the "Unna Boot". [004] It should be emphasized, preliminarily, that the term bandage is primarily defined as a strip of gauze or other fabric applied to a part of the body as a dressing or to support an organ. On the other hand, the term gauze defines a thin, transparent fabric of silk or cotton; gauze. Its definition is made considering the characteristics that gauze is an open-weave cotton fabric used in dressings, compresses, bandages, etc. [005] In general, the “Unna Boot” is a compressive dressing made in the form of a cotton bandage, which contains a zinc oxide paste, a substance known to help relieve skin irritation, as well as keep the area affected by the wound moist to the right degree, and the bandage itself, when finished, acts as a natural means of protection for the affected skin. [006] The current state of the art also includes patent application BR 20 2024 012901-1, filed on 06/24/2024, entitled “GAUZE BANDAGES FOR APPLICATION IN AREAS WITH SURGICAL INTERVENTION AND BODY DISEASES, WITH EMISSION OF FAR INFRARED RAYS”, which claims a way of obtaining gauze/bandage using yarns spun with the addition of bioactive minerals, using specific textile equipment that weaves these yarns into a fabric mesh forming the gauze/bandage, and then winding it to form a bobbin. [007] The aforementioned state-of-the-art document also requests protection for obtaining gauze/bandage with far-infrared emission action, gauze that is arranged in a roll that will receive a solution containing a vehicle for bioactive minerals, such minerals being composed of bioceramics, bamboo ash, among others that allow the action of emitting infrared; said solution, after drying and in a continuous process, is capable of allowing the obtaining of a roll of gauze/bandage duly endowed with bioactive minerals, being cut into longer pieces for bandages or shorter pieces for gauze. [008] The aforementioned state-of-the-art document thus addresses a product that can take the form of a bandage or gauze, which incorporates in its structure minerals with bioactive properties and which are known to be able to emit radiation in the form of far-infrared in response to heat absorbed, for example, from the body of the person on whom the bandage or gauze has been applied. STATE OF THE ART PROBLEMS [009] The “Unna Boot” technique has been used for over a century and has proven efficient for the purposes for which it was originally designed, and in this sense there are, in practice, no state-of-the-art problems that can be listed and associated with the “Unna Boot” technique. [010] However, this Invention Patent application addresses and proposes an expansion in the way the technique known as "Unna Boot" is used, insofar as it incorporates into the bandage with which it is performed a medicinal formulation that superlatively expands the therapeutic reach that this type of dressing normally presents. [011] For this reason and in accordance with what has already been said, the concept of the “Unna Boot” technique was and is extremely efficient in fulfilling the role it was intended for from the beginning and, starting from this level, the present Invention Patent application aims to expand its field of use, as well as its efficiency in the treatment of skin ailments. [012] With respect to the content cited in patent application BR 20 2024 012901-1, notably with regard to the claimed product version, that